AQR Capital Management
GBT

AQR Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

AQR Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,720
Closed -$1.27M – 2334
2022
Q3 		$1.27M Buy
+18,720
New +$1.03M ﹤0.01% 1412
2022
Q1 		– Sell
-7,091
Closed -$208K – 2329
2021
Q4 		$208K Buy
+7,091
New +$220K ﹤0.01% 2081
2021
Q3 		– Sell
-13,080
Closed -$428K – 2372
2021
Q2 		$428K Buy
13,080
+7,396
+130% +$289K ﹤0.01% 1952
2021
Q1 		$232K Sell
5,684
-629
-10% -$28.9K ﹤0.01% 2074
2020
Q4 		$271K Buy
6,313
+339
+6% +$16.7K ﹤0.01% 2001
2020
Q3 		$326K Sell
5,974
-29,370
-83% -$1.87M ﹤0.01% 1884
2020
Q2 		$2.23M Sell
35,344
-3,255
-8% -$223K ﹤0.01% 1111
2020
Q1 		$1.97M Buy
38,599
+18,596
+93% +$1.25M ﹤0.01% 1080
2019
Q4 		$1.59M Buy
20,003
+4,360
+28% +$258K ﹤0.01% 1354
2019
Q3 		$759K Buy
15,643
+3,836
+32% +$200K ﹤0.01% 1609
2019
Q2 		$621K Buy
+11,807
New +$679K ﹤0.01% 1661
2019
Q1 		– Sell
-8,390
Closed -$344K – 2247
2018
Q4 		$344K Sell
8,390
-11,416
-58% -$428K ﹤0.01% 1918
2018
Q3 		$753K Buy
19,806
+698
+4% +$30.9K ﹤0.01% 1812
2018
Q2 		$864K Sell
19,108
-7,855
-29% -$358K ﹤0.01% 1778
2018
Q1 		$1.3M Buy
26,963
+5,487
+26% +$306K ﹤0.01% 1560
2017
Q4 		$845K Buy
21,476
+4,362
+25% +$163K ﹤0.01% 1731
2017
Q3 		$531K Buy
17,114
+2,791
+19% +$78.5K ﹤0.01% 1919
2017
Q2 		$392K Buy
14,323
+8,881
+163% +$264K ﹤0.01% 1971
2017
Q1 		$201K Buy
+5,442
New +$137K ﹤0.01% 2113

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Capital Management's GBT Position: Q4 2022 in Review

AQR Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 18,720 shares — an estimated $1.27M sold.

AQR Capital Management first reported a position in GBT in Q1 2017 and held it in 19 quarters. The position peaked at $2.23M in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • AQR Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • AQR Capital Management sold 18,720 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.27M.
  • AQR Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 19 quarters.
  • AQR Capital Management's Global Blood Therapeutics, Inc. position peaked at $2.23M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.